[Viral hepatitis following administration of the 4 coagulation-factors concentrate PPSB]

[Article in Dutch]

[Article in Dutch]

H J Penn. Ned Tijdschr Geneeskd. 1979.

. 1979 Sep 1;123(35):1532-3.

No abstract available

Similar articles

Chronic liver disease and haemophilia.
[No authors listed] [No authors listed] Lancet. 1988 Dec 24-31;2(8626-8627):1465-6. Lancet. 1988. PMID: 2904578 No abstract available.
Replacement therapy with virus-inactivated clotting factor concentrates in patients with severe hemophilia in Heidelberg.
Zimmermann R, Uhle C, Huth-Kühne A. Zimmermann R, et al. Semin Thromb Hemost. 2002 Apr;28 Suppl 1:75-8. doi: 10.1055/s-2002-30199. Semin Thromb Hemost. 2002. PMID: 12016582 No abstract available.
No hepatitis after treatment with a modified factor IX concentrate in previously untreated hemophiliacs.
Mannucci PM, Morfini M, Gatti L, Rafanelli D, Colombo M, Geroldi D, Einarsson M, Zanetti AR. Mannucci PM, et al. Ann Intern Med. 1985 Aug;103(2):226-7. doi: 10.7326/0003-4819-103-2-226. Ann Intern Med. 1985. PMID: 4014905 No abstract available.
Evaluation of the risk of hepatitis from clotting factor concentrates.
Fricke WA. Fricke WA. Prog Clin Biol Res. 1990;324:161-6. Prog Clin Biol Res. 1990. PMID: 2408051 Review. No abstract available.
Transfusion support for haemophiliacs.
Allain JP. Allain JP. Clin Haematol. 1984 Feb;13(1):99-117. Clin Haematol. 1984. PMID: 6426835 Review. No abstract available.